HSBC Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.6M | Buy |
471,800
+370,400
| +365% | +$21.6M | 0.01% | 655 |
|
|
2025
Q4 | $5.5M | Buy |
+101,400
| New | +$4.88M | ﹤0.01% | 1167 |
|
|
2024
Q1 | – | Sell |
-64,800
| Closed | -$3.31M | – | 3061 |
|
|
2023
Q4 | $3.31M | Sell |
64,800
-40,000
| -38% | -$2.1M | ﹤0.01% | 1292 |
|
|
2023
Q3 | $6.08M | Sell |
104,800
-1,400
| -1% | -$85.8K | 0.01% | 1015 |
|
|
2023
Q2 | $6.82M | Sell |
106,200
-57,000
| -35% | -$3.82M | 0.01% | 940 |
|
|
2023
Q1 | $11.3M | Sell |
163,200
-189,700
| -54% | -$13.4M | 0.01% | 806 |
|
|
2022
Q4 | $25.2M | Buy |
352,900
+131,600
| +59% | +$9.92M | 0.03% | 570 |
|
|
2022
Q3 | $15.9M | Hold |
221,300
| – | – | 0.03% | 641 |
|
|
2022
Q2 | $17.1M | Buy |
+221,300
| New | +$16.9M | 0.02% | 634 |
|
|
2022
Q1 | – | Sell |
-500
| Closed | -$31K | – | 3270 |
|
|
2021
Q4 | $31K | Sell |
500
-23,000
| -98% | -$1.35M | ﹤0.01% | 3220 |
|
|
2021
Q3 | $1.39M | Sell |
23,500
-6,000
| -20% | -$395K | ﹤0.01% | 1713 |
|
|
2021
Q2 | $1.97M | Sell |
29,500
-3,900
| -12% | -$254K | ﹤0.01% | 1452 |
|
|
2021
Q1 | $2.11M | Sell |
33,400
-106,500
| -76% | -$6.63M | ﹤0.01% | 1291 |
|
|
2020
Q4 | $8.63M | Buy |
139,900
+99,000
| +242% | +$6.09M | 0.01% | 832 |
|
|
2020
Q3 | $2.47M | Sell |
40,900
-68,500
| -63% | -$4.12M | ﹤0.01% | 1201 |
|
|
2020
Q2 | $6.43M | Sell |
109,400
-515,300
| -82% | -$30.8M | 0.01% | 784 |
|
|
2020
Q1 | $34.9M | Buy |
624,700
+115,400
| +23% | +$7.05M | 0.08% | 226 |
|
|
2019
Q4 | $32.6M | Sell |
509,300
-575,700
| -53% | -$33M | 0.06% | 341 |
|
|
2019
Q3 | $55M | Buy |
1,085,000
+500,100
| +86% | +$23.5M | 0.1% | 198 |
|
|
2019
Q2 | $26.5M | Buy |
584,900
+170,900
| +41% | +$7.96M | 0.05% | 397 |
|
|
2019
Q1 | $19.8M | Buy |
414,000
+15,900
| +4% | +$792K | 0.04% | 514 |
|
|
2018
Q4 | $20.7M | Buy |
398,100
+52,100
| +15% | +$2.8M | 0.04% | 483 |
|
|
2018
Q3 | $21.5M | Buy |
346,000
+78,200
| +29% | +$4.64M | 0.03% | 523 |
|
|
2018
Q2 | $14.8M | Buy |
267,800
+161,700
| +152% | +$8.73M | 0.03% | 626 |
|
|
2018
Q1 | $6.71M | Buy |
+106,100
| New | +$6.83M | 0.01% | 988 |
|
|
2017
Q4 | – | Sell |
-336,200
| Closed | -$21.4M | – | 2069 |
|
|
2017
Q3 | $21.4M | Hold |
336,200
| – | – | 0.03% | 512 |
|
|
2017
Q2 | $18.7M | Sell |
336,200
-367,800
| -52% | -$20M | 0.03% | 532 |
|
|
2017
Q1 | $38.3M | Sell |
704,000
-35,700
| -5% | -$1.96M | 0.08% | 257 |
|
|
2016
Q4 | $43.2M | Buy |
739,700
+22,300
| +3% | +$1.22M | 0.1% | 223 |
|
|
2016
Q3 | $38.7M | Buy |
717,400
+273,700
| +62% | +$17.6M | 0.1% | 228 |
|
|
2016
Q2 | $32.6M | Buy |
443,700
+125,000
| +39% | +$8.83M | 0.09% | 256 |
|
|
2016
Q1 | $20.4M | Sell |
318,700
-139,700
| -30% | -$8.81M | 0.06% | 400 |
|
|
2015
Q4 | $31.5M | Buy |
458,400
+290,800
| +174% | +$19.2M | 0.08% | 292 |
|
|
2015
Q3 | $9.92M | Sell |
167,600
-396,558
| -70% | -$25.2M | 0.03% | 599 |
|
|
2015
Q2 | $37.5M | Buy |
564,158
+418,758
| +288% | +$27.6M | 0.08% | 268 |
|
|
2015
Q1 | $9.38M | Sell |
145,400
-244,300
| -63% | -$15.3M | 0.02% | 697 |
|
|
2014
Q4 | $23M | Buy |
389,700
+302,700
| +348% | +$17.1M | 0.05% | 408 |
|
|
2014
Q3 | $4.45M | Buy |
87,000
+34,600
| +66% | +$1.73M | 0.01% | 923 |
|
|
2014
Q2 | $2.54M | Buy |
52,400
+46,000
| +719% | +$2.27M | 0.01% | 1061 |
|
|
2014
Q1 | $332K | Sell |
6,400
-18,100
| -74% | -$963K | ﹤0.01% | 1508 |
|
|
2013
Q4 | $1.3M | Sell |
24,500
-30,000
| -55% | -$1.53M | ﹤0.01% | 1209 |
|
|
2013
Q3 | $2.52M | Buy |
+54,500
| New | +$2.39M | 0.01% | 1023 |
|
Other funds holding BMY
VCM
VPM
HSBC Holdings's BMY Position: Q1 2026 in Review
HSBC Holdings reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, selling an estimated $93.5M and leaving 4,821,508 shares worth $292M. The position accounts for 0.15% of the portfolio, ranked #120.
HSBC Holdings first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $425M in Q4 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- HSBC Holdings held 4,821,508 shares of Bristol-Myers Squibb worth $292M as of Q1 2026.
- HSBC Holdings sold 1,603,207 Bristol-Myers Squibb shares in Q1 2026, an estimated $93.5M.
- Bristol-Myers Squibb made up 0.15% of HSBC Holdings's portfolio in Q1 2026, its #120 holding.
- HSBC Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Bristol-Myers Squibb position peaked at $425M in Q4 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.